Lion Biotechnologies CEO Maria Fardis' 2020 pay jumps 120% to $9M
Lion Biotechnologies reports 2020 executive compensation
By ExecPay News
Published: April 27, 2021
Lion Biotechnologies reported fiscal year 2020 executive compensation information on April 27, 2021.
In 2020, six executives at Lion Biotechnologies received on average a compensation package of $3.4M, a 27% increase compared to previous year.
Average pay of disclosed executives at Lion Biotechnologies
Maria Fardis, Chief Executive Officer, received $9M in total, which increased by 120% compared to 2019. 90% of Fardis' compensation, or $8.1M, was in option awards. Fardis also received $300K in non-equity incentive plan and $600K in salary.
For fiscal year 2020, the median employee pay was $445,643 at Lion Biotechnologies. Therefore, the ratio of Maria Fardis' pay to the median employee pay was 20 to one.
Jean-Marc Bellemin, Chief Financial Officer, received a compensation package of $5M. 88% of the compensation package, or $4.4M, was in option awards.
Frederick G. Vogt, General Counsel, earned $3M in 2020, a 46% increase compared to previous year.
Friedrich Graf Finckenstein, Chief Medical Officer, received $1.8M in 2020, which decreases by 47% compared to 2019.
Michael Swartzburg, Former Vice President, Finance and interim Principal Financial Officer and Principal Accounting Officer, earned $1.1M in 2020.
Timothy E. Morris, Chief Financial Officer, received $482K in 2020, which decreases by 60% compared to 2019.
Related executives
Maria Fardis
Lion Biotechnologies
Chief Executive Officer
Jean-Marc Bellemin
Lion Biotechnologies
Chief Financial Officer
Friedrich Finckenstein
Lion Biotechnologies
Chief Medical Officer
Frederick Vogt
Lion Biotechnologies
General Counsel
Timothy Morris
Lion Biotechnologies
Chief Financial Officer
Michael Swartzburg
Lion Biotechnologies
Former Vice President, Finance and interim Principal Financial Officer and Principal Accounting Officer
You may also like
Source: SEC filing on April 27, 2021.